Biological psychology represents a fusion of several scientific disciplines - pharmacology, neurobiology, biochemistry, genetics, physiology, anatomy, biophysics and psychology. All are focussed on acquiring an ultimate understanding of the relationships between brain and behaviour. Presented in two volumes are the papers of the 5th World Congress of Biological Psychiatry. Together they represent a significant contribution to complementary advances across a broad front of recently developed research areas. Psychiatric disorders include schizophrenia, affective disorders, the many forms of senile and presenile dementia including Alzheimer's disease, the anxiety disorders, childhood disorders and the variants of eating and sleeping dysfunctions. Each of these illnesses represents a complex interaction of biological, psychological and social variables. The growing number of neuroscientists adopting the biological approach to neuropsychiatric diseases has resulted in a fast expanding body of knowledge regarding brain function and pathology.
Further, psychotherapeutic drugs used to treat psychiatric and neurologic disorders play a crucial role in elucidating the biological bases of these diseases. Studying the mechanism of action of these compounds should give us important clues about the normal and pathological functioning of the brain.
Biological psychology represents a fusion of several scientific disciplines - pharmacology, neurobiology, biochemistry, genetics, physiology, anatomy, biophysics and psychology. All are focussed on acquiring an ultimate understanding of the relationships between brain and behaviour. Presented in two volumes are the papers of the 5th World Congress of Biological Psychiatry. Together they represent a significant contribution to complementary advances across a broad front of recently developed research areas. Psychiatric disorders include schizophrenia, affective disorders, the many forms of senile and presenile dementia including Alzheimer's disease, the anxiety disorders, childhood disorders and the variants of eating and sleeping dysfunctions. Each of these illnesses represents a complex interaction of biological, psychological and social variables. The growing number of neuroscientists adopting the biological approach to neuropsychiatric diseases has resulted in a fast expanding body of knowledge regarding brain function and pathology.
Further, psychotherapeutic drugs used to treat psychiatric and neurologic disorders play a crucial role in elucidating the biological bases of these diseases. Studying the mechanism of action of these compounds should give us important clues about the normal and pathological functioning of the brain.
Reihe
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Technology
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Maße
ISBN-13
978-0-444-89295-9 (9780444892959)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
ALCOHOLISM, DRUG DEPENDENCE AND ABUSE. Alcoholism: Molecular mechanism and new treatments (5 papers). Clinical neurophysiology of substance abuse (3 papers). Neurobiology of drug addiction (4 papers). New strategies in pharmacological treatment of substance abuse disorders (5 papers). Developmental neurobehavioural effects of psychotropic drugs and drugs abuse (5 papers). AGING AND DEMENTIA: CLINICAL AND BIOLOGICAL RESEARCH. HIV-1 associated dementia (6 papers). Cognitive impairment in psychiatric diseases: Basic and clinical investigations (4 papers). Neuroimmunomodulation in ageing (1 paper). Neurobiology of ageing and Alzheimer disease (14 papers). Pharmacological treatment of mental and cognitive disorders in ageing (3 papers). ANTICONVULSANTS, EPILEPSY AND ORGANIC MENTAL DISORDERS. Pharmacotherapy of brain lesions (6 papers). Biological basis of ictal, perictal and interictal behavioural changes in epilepsy (5 papers). Kindling, psychiatry and anticonvulsant drugs (4 papers). Limbic system surgery in the treatment of severe refractory psychiatric illness (8 papers). Carbamazepine and other anticonvulsants in the treatment of psychiatric disorders (6 papers). EATING DISORDERS: BASIC AND CLINICAL RESEARCH. Neuronal basis of eating behaviour and appetite disorder: Organization of the system (5 papers). Clinical aspects of bulimia nervosa (6 papers). Psychobiology of eating disorders (6 papers). BIOLOGICAL MARKERS, BRAIN IMAGING, EVOKED POTENTIALS AND EEG MAPPING. Plasma amino acids: Markers, predictors, therapeutical tools for psychiatric disease (4 papers). Plasma dexamethazone and the DST (3 papers). Platelets: Useful tools in neuropsychiatric disorders (4 papers). Magnetic resonance imaging and psychoses (6 papers). Brain receptor imaging in psychoses (2 papers). EEG functional mapping: Disease and treatment states (4 papers). Event related potentials in psychiatry (5 papers). Pharmaco-EEG and EEG mapping (4 papers). GENETICS IN PSYCHIATRY: BASIC AND CLINICAL ASPECTS. Transgenic animals as experimental models in neuroimmunology (1 paper). Molecular genetics of affective illnesses (4 papers). Molecular genetics of psychoses (5 papers). The X chromosome in psychiatric diseases (6 papers). Cytogenetics of psychiatric disease (3 papers). Continuity or discontinuity in psychotic illness: Kraepelin versus his antagonists (3 papers). NEUROPEPTIDES AND PSYCHONEUROIMMUNOENDOCRINOLOGY. Psychotropic actions of non-peptidergic hormones: Clinical and basic sciences perspectives (2 papers). An appraisal of use of neuropeptides as putative therapeutic agents in brain disorders (4 papers). Peptides - Relevance for psychiatric disorders (4 papers). Role of neuropeptides in the pathogenesis of affective disorders (5 papers). Immunological aspects of psychiatric disorders (1 paper). Psychoneuroimmunoendocrinology: A new research pathway (6 papers). NEUROTRANSMITTERS, RECEPTOR MOLECULAR BIOLOGY, BRAIN SIGNAL TRANSDUCTIONS AND BEHAVIOUR.
